首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1561043

微射流市場規模、佔有率、成長分析、按產品、按材料、按應用、按最終用戶、按地區 - 行業預測，2024-2031 年

Microfluidics Market Size, Share, Growth Analysis, By Product, By Material, By Application, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年09月18日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年微射流的全球市場規模為217億美元，從2023年的244.8億美元成長到2031年的641.6億美元，在預測期內（2024-2031年）預計複合年成長率為12.8%。

與傳統流體測量裝置相比，微流體系統提高了參數控制和資料質量，同時需要更少的樣品和更小的設備。因此，它廣泛應用於 PCR 擴增、細胞分離和 DNA 分析等應用。各種健康挑戰推動了對這些技術的需求不斷成長。例如，PLOS One 1 月發表的一項研究預測，到 2025 年，法國將有約 280 萬慢性阻塞性肺病(COPD) 病例。預計這將重振使用微流體晶片和小血樣的慢性阻塞性肺病檢測市場。同樣，澳洲失智症協會 2022 年的資料顯示，當年有 487,500 名澳洲人患有失智症，預計到 2058 年這一數字將增至 110 萬人。隨著失智症率的上升，對有效藥物發現、篩檢方法和毒理學研究的需求日益增加。微流體系統可以透過促進骨骼、神經膠質和內皮細胞的發育並維持肌肉細胞的流體隔離來支持這些努力，同時能夠研究器官發育和疾病機制。微流體設備在各種研究和診斷領域的使用越來越多，預計將推動市場成長。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Thermo Fisher Scientific（US）
Becton, Dickinson, and Company（US）
Agilent Technologies（US）
Bio-Rad Laboratories（US）
F. Hoffmann-La Roche（Switzerland）
Danaher Corporation（US）
Illumina Inc.（US）
Fluidigm Corporation（US）
Abbott Laboratories（US）
BioMerieux（France）
Hologic（US）
Quidel Corporation（US）
SMC Corporation（Japan）
Parker-Hannifin Corporation（US）
IDEX Corporation（US）
Fortive Corporation（US）
Aignep SpA（Italy）
Dolomite Microfluidics（UK）
Elveflow（France）
uFluidix（Canada）
NanoString Technologies（US）
Nortis Inc.（US）
Innovative Biochips, LLC（US）
Fluidic Analytics（UK）

簡介目錄

Product Code: SQMIG35A2288

Global Microfluidics Market size was valued at USD 21.70 billion in 2022 and is poised to grow from USD 24.48 billion in 2023 to USD 64.16 billion by 2031, growing at a CAGR of 12.8% during the forecast period (2024-2031).

Microfluidic systems offer enhanced parameter control and data quality while requiring fewer samples and smaller instruments compared to traditional fluid measuring equipment. As a result, they are widely used in applications such as PCR amplification, cell separation, and DNA analysis. The growing demand for these technologies is driven by various health challenges. For instance, a study published in PLOS One in January predicts that France will have approximately 2.8 million cases of chronic obstructive pulmonary disease (COPD) by 2025. This is expected to boost the market for COPD testing through microfluidic chips and small blood samples. Similarly, data from Dementia Australia in 2022 shows that 487,500 Australians were living with dementia in that year, and the number is forecasted to increase to 1.1 million by 2058. With rising dementia rates, there is an increasing need for efficient drug discovery, screening methods, and toxicology studies. Microfluidic systems can support these efforts by facilitating the development of skeletal, glial, and endothelial cells, enabling research into organ development and disease mechanisms while maintaining fluid isolation of muscle cells. The expanding use of microfluidic devices across various research and diagnostic fields is expected to drive market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microfluidics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microfluidics Market Segmental Analysis

Global Microfluidics Market is segmented by Product, Material, application, end user and region. Based on Product, the market is segmented into Microfluidics-based Device, Microfluidic Components. Based on Material, the market is segmented into Glass, Silicon, Polymer, and Others. Based on Application, the market is segmented into In Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing, Therapeutics. Based on End User, the market is segmented into Hospital and Diagnostic Centers, Academic and Research Institute, Pharmaceutical & Biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Microfluidics Market

The adoption of microfluidic devices in personalized medicine is on the rise due to their capacity to deliver high-throughput and high-quality results. As personalized medicine continues to gain traction, the demand for microfluidic devices is expected to grow accordingly. These devices are particularly well-suited for point-of-care diagnostics, offering portability, affordability, and the ability to work with minimal sample volumes. With the increasing need for quick and accurate diagnostic tests, the use of microfluidic devices is projected to expand significantly, making them a crucial tool in modern healthcare diagnostics.

Restraints in the Global Microfluidics Market

The production of microfluidic devices involves intricate manufacturing processes that demand a high level of precision and specialized expertise. Due to the complexity involved, achieving consistent quality and performance can be challenging, making the development of these devices a highly technical endeavor. As a result, scaling up production while maintaining cost efficiency becomes difficult for companies in this sector. The need for precise fabrication techniques often leads to higher manufacturing costs, posing a barrier to reducing prices and expanding market accessibility.

Market Trends of the Global Microfluidics Market

Point-of-care testing (POCT) involves conducting medical diagnostic tests outside traditional clinical laboratories, such as in doctor's offices, hospital rooms, or even at home. Its popularity is rising due to the convenience and rapid results it provides, making it an attractive option for both patients and healthcare providers. Microfluidic devices are particularly well-suited for POCT because of their efficiency and portability. As the demand for faster and more accessible testing grows, so does the need for microfluidic devices designed for point-of-care applications.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Trade Analysis
Supply chain Analysis
Case study Analysis
Patent Analysis
Customer & Buying Criteria Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Microfluidics Market by Product

Market Overview
Microfluidics-based Device
Microfluidic Components
- Microfluidic Chip
- Flow And Pressure Sensors
- Flow And Pressure Controllers
- Micropumps
- Microfluidic Valves
- Microneedles
- Other Components

Microfluidics Market by Material

Market Overview
Glass
Silicon
Polymer
Others

Microfluidics Market by Application

Market Overview
In Vitro Diagnostics
- Clinical Diagnostics
- Point of Care Testing
- Veterinary Diagnostics
Pharmaceutical & Life Science Research and Manufacturing
- Lab Analytics
- Proteomic analysis
- Genomic analysis
- Cell-based assays
- Capillary electrophoresis
- Microdispensing
- Microreaction
Therapeutics
- Drug Delivery
- Wearable Devices

Microfluidics Market by End-user

Market Overview
Hospital and Diagnostic Centers
Academic and Research Institute
Pharmaceutical & Biotechnology Companies

Microfluidics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Thermo Fisher Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson, and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluidigm Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioMerieux (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quidel Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SMC Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Parker-Hannifin Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IDEX Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fortive Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aignep S.p.A (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dolomite Microfluidics (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elveflow (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
uFluidix (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NanoString Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nortis Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Innovative Biochips, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluidic Analytics (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments